These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
396 related items for PubMed ID: 9009951
1. Role of renal cysteine conjugate beta-lyase in the mechanism of compound A nephrotoxicity in rats. Kharasch ED, Thorning D, Garton K, Hankins DC, Kilty CG. Anesthesiology; 1997 Jan; 86(1):160-71. PubMed ID: 9009951 [Abstract] [Full Text] [Related]
2. Role of the renal cysteine conjugate beta-lyase pathway in inhaled compound A nephrotoxicity in rats. Kharasch ED, Hoffman GM, Thorning D, Hankins DC, Kilty CG. Anesthesiology; 1998 Jun; 88(6):1624-33. PubMed ID: 9637657 [Abstract] [Full Text] [Related]
7. In vivo nephrotoxic action of an isomeric mixture of S-(1-phenyl-2-hydroxyethyl)glutathione and S-(2-phenyl-2-hydroxyethyl)glutathione in Fischer-344 rats. Chakrabarti S, Malick MA. Toxicology; 1991 Mar 25; 67(1):15-27. PubMed ID: 1673268 [Abstract] [Full Text] [Related]
8. Role of cytochrome P4503A in cysteine S-conjugates sulfoxidation and the nephrotoxicity of the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A) in rats. Sheffels P, Schroeder JL, Altuntas TG, Liggitt HD, Kharasch ED. Chem Res Toxicol; 2004 Sep 25; 17(9):1177-89. PubMed ID: 15377151 [Abstract] [Full Text] [Related]
11. Cysteine conjugate beta-lyase-dependent metabolism of compound A (2-[fluoromethoxy]-1,1,3,3,3-pentafluoro-1-propene) in human subjects anesthetized with sevoflurane and in rats given compound A. Iyer RA, Frink EJ, Ebert TJ, Anders MW. Anesthesiology; 1998 Mar 25; 88(3):611-8. PubMed ID: 9523802 [Abstract] [Full Text] [Related]
12. Cysteine conjugate beta-lyase-dependent biotransformation of the cysteine S-conjugates of the sevoflurane degradation product 2-(fluoromethoxy)-1,1,3,3,3-pentafluoro-1-propene (compound A). Iyer RA, Anders MW. Chem Res Toxicol; 1997 Jul 25; 10(7):811-9. PubMed ID: 9250416 [Abstract] [Full Text] [Related]
13. Influence of sevoflurane on the metabolism and renal effects of compound A in rats. Kharasch ED, Schroeder JL, Sheffels P, Liggitt HD. Anesthesiology; 2005 Dec 25; 103(6):1183-8. PubMed ID: 16306730 [Abstract] [Full Text] [Related]
14. Mechanism of S-(1,2-dichlorovinyl)glutathione-induced nephrotoxicity. Elfarra AA, Jakobson I, Anders MW. Biochem Pharmacol; 1986 Jan 15; 35(2):283-8. PubMed ID: 2867768 [Abstract] [Full Text] [Related]
15. Quantitative differences in the production and toxicity of CF2=BrCl versus CH2F-O-C(=CF2)(CF3) (compound A): the safety of halothane does not indicate the safety of sevoflurane. Eger EI, Ionescu P, Laster MJ, Gong D, Weiskopf RB, Kerschmann RL. Anesth Analg; 1997 Nov 15; 85(5):1164-70. PubMed ID: 9356119 [Abstract] [Full Text] [Related]
16. Biotransformation of L-cysteine S-conjugates and N-acetyl-L-cysteine S-conjugates of the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A) in human kidney in vitro: interindividual variability in N-acetylation, N-deacetylation, and beta-lyase-catalyzed metabolism. Gul Altuntas T, Kharasch ED. Drug Metab Dispos; 2002 Feb 15; 30(2):148-54. PubMed ID: 11792683 [Abstract] [Full Text] [Related]
17. Nephrotoxicity of 4-amino-3-S-glutathionylphenol and its modulation by metabolism or transport inhibitors. Fowler LM, Foster JR, Lock EA. Arch Toxicol; 1994 Feb 15; 68(1):15-23. PubMed ID: 7909430 [Abstract] [Full Text] [Related]
18. Effects of probenecid on renal function in surgical patients anesthetized with low-flow sevoflurane. Higuchi H, Wada H, Usui Y, Goto K, Kanno M, Satoh T. Anesthesiology; 2001 Jan 15; 94(1):21-31. PubMed ID: 11135718 [Abstract] [Full Text] [Related]
19. 4-Amino-2,6-dichlorophenol nephrotoxicity in the Fischer 344 rat: protection by ascorbic acid, AT-125, and aminooxyacetic acid. Hong SK, Anestis DK, Ball JG, Valentovic MA, Brown PI, Rankin GO. Toxicol Appl Pharmacol; 1997 Nov 15; 147(1):115-25. PubMed ID: 9356314 [Abstract] [Full Text] [Related]
20. Dose-dependent metabolism of fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A), an anesthetic degradation product, to mercapturic acids and 3,3,3-trifluoro-2-(fluoromethoxy)propanoic acid in rats. Kharasch ED, Jubert C, Spracklin DK, Hoffman GM. Toxicol Appl Pharmacol; 1999 Oct 01; 160(1):49-59. PubMed ID: 10502502 [Abstract] [Full Text] [Related] Page: [Next] [New Search]